Key Insights

Highlights

Treatment Research

2 treatments under study, led by Ketamine Hydrochloride

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Early Phase 1 (1)
Phase 1 (1)

Trial Status

Unknown1
Withdrawn1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06062628Early Phase 1Withdrawn

Ketamine in Severe Traumatic Brain Injury

NCT05490576Phase 1Unknown

Tau And Connectomics In TES Study

Showing all 2 trials

Research Network

Common Treatments

  • Ketamine Hydrochloride1
  • 18f Pi2620 Tau Ligand1

Active Sponsors

  • University of Texas Southwestern Medical Center1
  • Macquarie University, Australia1
  • Life Molecular Imaging GmbH1
  • Omniscient Neurotechnology1

Top Investigators

Related Conditions

  • Neurodegenerative Diseases1
  • Cognitive Impairment1
  • Traumatic Brain Injury1
  • Head Injury Trauma1
  • Chronic Traumatic Encephalopathy1

Activity Timeline